schliessen

Filtern

 

Bibliotheken

SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: proquest1273253289
title: New prostate cancer drugs hold promise.
format: Article
creator:
  • Printz, Carrie
subjects:
  • Androstenes–Therapeutic Use
  • Androstenols–Therapeutic Use
  • Antineoplastic Agents–Analogs & Derivatives
  • Clinical Trials As Topic–Therapeutic Use
  • Drug Approval–Drug Therapy
  • Humans–Mortality
  • Male–Therapeutic Use
  • Phenylthiohydantoin–Therapeutic Use
  • Prostatic Neoplasms–Therapeutic Use
  • Taxoids–Therapeutic Use
  • Tissue Extracts–Therapeutic Use
  • United States–Therapeutic Use
  • Abridged
  • Androstenes
  • Androstenols
  • Antineoplastic Agents
  • Mdv 3100
  • Taxoids
  • Tissue Extracts
  • Phenylthiohydantoin
  • Cabazitaxel
  • Sipuleucel-T
  • Abiraterone
ispartof: Cancer, January 15, 2013, Vol.119(2), pp.247-248
description:
language: eng
source:
identifier: E-ISSN: 1097-0142 ; DOI: 1097-0142 ; DOI: 10.1002/cncr.27943
fulltext: fulltext
issn:
  • 10970142
  • 1097-0142
url: Link


@attributes
ID292553243
RANK0.07
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
LOCALfalse
PrimoNMBib
record
control
sourcerecordid1273253289
sourceidproquest
recordidTN_proquest1273253289
sourcesystemOther
pqid1273253289
galeid315944433
display
typearticle
titleNew prostate cancer drugs hold promise.
contributorNational Library of Medicine (record owner)
ispartofCancer, January 15, 2013, Vol.119(2), pp.247-248
identifier
subjectAndrostenes–Therapeutic Use ; Androstenols–Therapeutic Use ; Antineoplastic Agents–Analogs & Derivatives ; Clinical Trials As Topic–Therapeutic Use ; Drug Approval–Drug Therapy ; Humans–Mortality ; Male–Therapeutic Use ; Phenylthiohydantoin–Therapeutic Use ; Prostatic Neoplasms–Therapeutic Use ; Taxoids–Therapeutic Use ; Tissue Extracts–Therapeutic Use ; United States–Therapeutic Use ; Abridged ; Androstenes ; Androstenols ; Antineoplastic Agents ; Mdv 3100 ; Taxoids ; Tissue Extracts ; Phenylthiohydantoin ; Cabazitaxel ; Sipuleucel-T ; Abiraterone
languageeng
source
creatorPrintz, Carrie;
version6
lds50peer_reviewed
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
backlink$$Uhttp://search.proquest.com/docview/1273253289/?pq-origsite=primo$$EView_record_in_ProQuest_(subscribers_only)
search
titleNew prostate cancer drugs hold promise.
subject
0Androstenes–Therapeutic Use
1Androstenols–Therapeutic Use
2Antineoplastic Agents–Analogs & Derivatives
3Clinical Trials As Topic–Therapeutic Use
4Drug Approval–Drug Therapy
5Humans–Mortality
6Male–Therapeutic Use
7Phenylthiohydantoin–Therapeutic Use
8Prostatic Neoplasms–Therapeutic Use
9Taxoids–Therapeutic Use
10Tissue Extracts–Therapeutic Use
11United States–Therapeutic Use
12Abridged
13Androstenes
14Androstenols
15Antineoplastic Agents
16Mdv 3100
17Taxoids
18Tissue Extracts
19Phenylthiohydantoin
20Cabazitaxel
21Sipuleucel-T
22Abiraterone
general
0English
11097-0142
210.1002/cncr.27943
3MEDLINE (ProQuest)
4ProQuest Biological Science Collection
5ProQuest Natural Science Collection
6ProQuest SciTech Collection
7Biological Science Database
8Natural Science Collection
9SciTech Premium Collection
10Health Research Premium Collection
11Health Research Premium Collection (Alumni edition)
sourceidproquest
recordidproquest1273253289
issn
010970142
11097-0142
rsrctypenewspaper_article
creationdate2013
addtitleCancer
searchscope
01007527
11007944
210000004
310000038
410000050
510000120
610000159
710000238
810000253
910000260
1010000270
1110000271
1210000302
13proquest
scope
01007527
11007944
210000004
310000038
410000050
510000120
610000159
710000238
810000253
910000260
1010000270
1110000271
1210000302
13proquest
lsr43
01007527false
11007944false
210000004false
310000038false
410000050false
510000120false
610000159false
710000238false
810000253false
910000260false
1010000270false
1110000271false
1210000302false
contributorNational Library of Medicine
startdate20130115
enddate20130115
citationpf 247 pt 248 vol 119 issue 2
lsr30VSR-Enriched:[pqid, creator, galeid, issn]
sort
titleNew prostate cancer drugs hold promise.
authorNational Library of Medicine (record owner)
creationdate20130115
lso0120130115
facets
frbrgroupid6282395253223308798
frbrtype5
newrecords20181218
languageeng
creationdate2013
topic
0Androstenes–Therapeutic Use
1Androstenols–Therapeutic Use
2Antineoplastic Agents–Analogs & Derivatives
3Clinical Trials As Topic–Therapeutic Use
4Drug Approval–Drug Therapy
5Humans–Mortality
6Male–Therapeutic Use
7Phenylthiohydantoin–Therapeutic Use
8Prostatic Neoplasms–Therapeutic Use
9Taxoids–Therapeutic Use
10Tissue Extracts–Therapeutic Use
11United States–Therapeutic Use
12Abridged
13Androstenes
14Androstenols
15Antineoplastic Agents
16Mdv 3100
17Taxoids
18Tissue Extracts
19Phenylthiohydantoin
20Cabazitaxel
21Sipuleucel-T
22Abiraterone
collection
0MEDLINE (ProQuest)
1ProQuest Biological Science Collection
2ProQuest Natural Science Collection
3ProQuest SciTech Collection
4Biological Science Database
5Natural Science Collection
6SciTech Premium Collection
7Health Research Premium Collection
8Health Research Premium Collection (Alumni edition)
prefilternewspaper_articles
rsrctypenewspaper_articles
creatorcontribNational Library of Medicine
jtitleCancer
toplevelpeer_reviewed
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
addauNational Library of Medicine
atitleNew prostate cancer drugs hold promise.
jtitleCancer
risdate20130115
volume119
issue2
spage247
epage248
pages247-248
eissn1097-0142
doi10.1002/cncr.27943
urlhttp://search.proquest.com/docview/1273253289/
issn0008543X
date2013-01-15
genrearticle
formatjournal
ristypeJOUR